The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Open accessAbstract
Mutations in the gene encoding the transcriptional repressor methyl-CpG binding protein 2 (MeCP2) cause the neurodevelopmental disorder Rett syndrome. Loss of function as well as increased dosage of the MECP2 gene cause a host of neuropsychiatric disorders. To explore the molecular mechanism(s) underlying these disorders, we examined gene expression patterns in the hypothalamus of mice that either lack or overexpress MeCP2. In both models, MeCP2 dysfunction induced changes in the expression levels of thousands of genes, but unexpectedly the majority of genes (∼85%) appeared to be activated by MeCP2. We selected six genes and confirmed that MeCP2 binds to their promoters. Furthermore, we showed that MeCP2 associates with the transcriptional activator CREB1 at the promoter of an activated target but not a repressed target. These studies suggest that MeCP2 regulates the expression of a wide range of genes in the hypothalamus and that it can function as both an activator and a repressor of transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While Mecp2 mutant mice are an excellent model for RTT, elimination of MeCP2 affects the expression of a profound number of pathways in the CNS, making it difficult to pinpoint which ones play a key role in pathology [77,89,90].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, MeCP2 may also facilitate transcriptional activation [77], chromatin compaction [78,79] and mRNA splicing [80,81], while also interacting with a host of other regulatory proteins involved in a variety of molecular pathways [81–84].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Altogether, multiple studies suggest that genes can be activated or repressed by MeCP2, depending upon the cellular context [77,89,90], suggesting that MeCP2 may be defined as a transcriptional modulator.”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
In the citing paper
“These data are consistent with another study showing that MeCP2 binding to methylated DNA has a biphasic impact on transcription.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Self-citationNan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Self-citationThe disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Chang, Q., Khare, G., Dani, V., Nelson, S., & Jaenisch, R. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.027 · Cited by 578
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- C. L. Martinet al., Am. J. Med. Genet. B. Neuropsychiatr. Genet.144, 869 (2007).
- H. Caldeira Araujoet al., Am. J. Med. Genet. A.133, 122 (2005).
- We thank members of the Zoghbi laboratory for their thoughtful comments Z. Yin for technical assistance M. Shinawi and A. Tawil for technical advice Y. Klisch for the art work and J. Lim J. Neul and M. Greenberg for reagents. The Baylor College of Medicine Microarray Core Facility performed the microarray experiments. This work was funded by NIH/National Institute of Neurological Disorders and Stroke grant NS057819 (H.Z.) National Institute of Child Health and Human Development Mental Retardation and Developmental Disabilities Research Center HD024064 (H.Z.) the International Rett Syndrome Foundation and the Simons Foundation. H.Z. is a Howard Hughes Medical Institute investigator. The microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo) and are accessible through GEO Series accession number GSE11150.
Cited by
Sorted by citations
Items 201–300 of 999
Na, E. S., Nelson, E. D., Adachi, M., Autry, A. E., Mahgoub, M., Kavalali, E. T., & Monteggia, L. M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6000-11.2012 · Cited by 133
Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome
Großer, E., Hirt, U., Janc, O. A., Menzfeld, C., Fischer, M., Kempkes, B., Vogelgesang, S., Manzke, T., Opitz, L., Salinas, G., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.007 · Cited by 136
The Role of Epigenetic Mechanisms in the Regulation of Gene Expression in the Nervous System
Cholewa-Waclaw, J., Bird, A. P., von Schimmelmann, M. J., Schaefer, A., Yu, H., Song, H., Madabhushi, R., & Tsai, L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2492-16.2016 · Cited by 137
Rett Syndrome: A Genetic Update and Clinical Review Focusing on Comorbidities
Gold, W. A., Krishnaraj, R. R., Ellaway, C., & Christodoulou, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00346 · Cited by 137
Mammalian epigenetic mechanisms
Zhang, G., & Pradhan, S. (2014) · IUBMB Life · doi:10.1002/iub.1264 · Cited by 143
Experimental models of Rett syndrome based on Mecp2 dysfunction
Calfa, G. D., Percy, A. K., & Pozzo‐Miller, L. D. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010261 · Cited by 136
Cognitive neuroepigenetics: A role for epigenetic mechanisms in learning and memory
Day, J. J., & Sweatt, J. D. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.12.008 · Cited by 137
Jiang, M., Ash, R. T., Baker, S. A., Suter, B., Ferguson, A., Park, J., Rudy, J., Torsky, S. P., Chao, H.-T., Zoghbi, H. Y., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1745-13.2013 · Cited by 129
Self-citationCell-Type-Specific Repression by Methyl-CpG-Binding Protein 2 Is Biased toward Long Genes
Sugino, K., Hempel, C. M., Okaty, B. W., Arnson, H. A., Kato, S., Dani, V. S., & Nelson, S. B. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2674-14.2014 · Cited by 132
BNDF methylation in mothers and newborns is associated with maternal exposure to war trauma
Kertes, D. A., Bhatt, S., Kamin, H. S., Hughes, D. A., Rodney, N. C., & Mulligan, C. J. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0367-x · Cited by 131
Epigenetic Treatments for Cognitive Impairments
Day, J. J., & Sweatt, J. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.85 · Cited by 132
Schepanski, S. N., Buß, C., Hanganu‐Opatz, I. L., & Arck, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02186 · Cited by 137
Hite, K. C., Adams, V. H., & Hansen, J. C. (2009) · Biochemistry and Cell Biology · doi:10.1139/o08-115 · Cited by 132
Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome
De Felice, C., Della Ragione, F., Signorini, C., Leoncini, S., Pecorelli, A., Ciccoli, L., Scalabrì, F., Marracino, F., Madonna, M., Belmonte, G., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.006 · Cited by 126
Ure, K., Lü, H., Wang, W., Ito, A., Wu, Z., He, L.-J., Sztainberg, Y., Chen, W., Tang, J., & Zoghbi, H. Y. (2016) · eLife · doi:10.7554/elife.14198 · Cited by 133
Self-citationPark, C., Hahn, O., Gupta, S. K., Moreno, A. J., Marino, F., Kedir, B., Wang, D., Villeda, S., Wyss‐Coray, T., & Dubal, D. B. (2023) · Nature Aging · doi:10.1038/s43587-023-00468-0 · Cited by 133
Loss of MeCP2 From Forebrain Excitatory Neurons Leads to Cortical Hyperexcitation and Seizures
Zhang, W., Peterson, M., Beyer, B., Frankel, W. N., & Zhang, Z.-W. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4900-12.2014 · Cited by 125
Nardone, S., & Elliott, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00329 · Cited by 138
Stress and the epigenetic landscape: a link to the pathobiology of human diseases?
Johnstone, S. E., & Baylin, S. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2881 · Cited by 131
Tang, X., Drotar, J., Li, K., Clairmont, C. D., Brumm, A. S., Sullins, A., Wu, H., Liu, X. S., Wang, J., Gray, N. S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau0164 · Cited by 120
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing
Renthal, W. R., Boxer, L. D., Hrvatin, S., Li, E., Silberfeld, A., Nagy, M. A., Griffith, E. C., Vierbuchen, T., & Greenberg, M. E. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0270-6 · Cited by 122
Regulation of brain-derived neurotrophic factor expression in neurons.
Zheng, F., Zhou, X., Moon, C., & Wang, H. (2012) · PubMed · Cited by 128
Self-citationEpigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
Maity, S., Farrell, K., Navabpour, S., Narayanan, S. N., & Jarome, T. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212280 · Cited by 130
Camuso, S., Rosa, P. L., Fiorenza, M. T., & Canterini, S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105606 · Cited by 126
Macholán, M., Baird, S. J. E., Dufková, P., Munclinger, P., Bímová, B. V., & Piálek, J. (2011) · Evolution · doi:10.1111/j.1558-5646.2011.01228.x · Cited by 119
DNA methylation in the gene body influences MeCP2-mediated gene repression
Kinde, B., Wu, D. Y., Greenberg, M. E., & Gabel, H. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618737114 · Cited by 118
Jefferson, A., Leonard, H., Siafarikas, A., Woodhead, H., Fyfe, S., Ward, L. M., Munns, C. F., Motil, K. J., Tarquinio, D. C., Shapiro, J. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146824 · Cited by 122
Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome
Johnson, B. S., Zhao, Y.-T., Fasolino, M., Lamonica, J. M., Kim, Y. J., Georgakilas, G. K., Wood, K. H., Bu, D. D., Cui, Y., Goffin, D., et al. (2017) · Nature Medicine · doi:10.1038/nm.4406 · Cited by 120
Epigenetics, Autism Spectrum, and Neurodevelopmental Disorders
Rangasamy, S., D’Mello, S. R., & Narayanan, V. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0227-0 · Cited by 122
Hirst, M., & Marra, M. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.011 · Cited by 120
Kuhn, D. E., Nuovo, G. J., Terry, A. V., Martin, M. M., Malana, G. E., Sansom, S. E., Pleister, A. P., Beck, W. D., Head, E., Feldman, D. S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033407 · Cited by 121
RetractedFoxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c
Chen, Y.-C., Kuo, H., Bornschein, U., Takahashi, H., Chen, S.-Y., Lu, K.-M., Yang, H.-Y., Chen, G.-M., Lin, J.-R., Lee, Y.-H., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4380 · Cited by 115
Roles of mitochondria in neuronal development
Son, G., & Han, J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.11.226 · Cited by 121
Unique Physical Properties and Interactions of the Domains of Methylated DNA Binding Protein 2
Ghosh, R. P., Tv, N., Horowitz-Scherer, R. A., Gierasch, L. M., Uversky, V. N., Hite, K. C., Hansen, J. C., & Woodcock, C. L. F. (2010) · Biochemistry · doi:10.1021/bi9019753 · Cited by 119
Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain
Basil, P., Li, Q., Dempster, E. L., Mill, J., Sham, P.-C., Wong, C. C. Y., & McAlonan, G. M. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.80 · Cited by 116
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L. I., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 118
μ opioid receptor, social behaviour and autism spectrum disorder: reward matters
Pellissier, L. P., Gandía, J., Laboute, T., Becker, J. A. J., & Merrer, J. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13808 · Cited by 115
Statins and the Brain: More than Lipid Lowering Agents?
Fracassi, A., Marangoni, M., Rosso, P., Pallottini, V., Fioramonti, M., Siteni, S., & Segatto, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170703101816 · Cited by 116
The Neuron Identity Problem: Form Meets Function
Fishell, G., & Heintz, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.035 · Cited by 115
miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes
Tsujimura, K., Irie, K., Nakashima, H., Egashira, Y., Fukao, Y., Fujiwara, M., Itoh, M., Uesaka, M., Imamura, T., Nakahata, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.028 · Cited by 118
Booij, L., Wang, D., Lévesque, M. L., Tremblay, R. E., & Szyf, M. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0251 · Cited by 122
Shulyakova, N., Andreazza, A. C., Mills, L. R., & Eubanks, J. H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00058 · Cited by 118
Tundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 120
Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome
Urdinguio, R. G., Lopez‐Serra, L., López‐Nieva, P., Alaminos, M., Díaz‐Uriarte, R., Fernández, A. F., & Esteller, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003669 · Cited by 121
Cortés‐Mendoza, J., de León‐Guerrero, S. D., Pedraza‐Alva, G., & Pérez‐Martínez, L. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.04.003 · Cited by 117
Complexities of Rett Syndrome and MeCP2: Figure 1.
Samaco, R. C., & Neul, J. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0169-11.2011 · Cited by 117
Olson, C. O., Zachariah, R. M., Ezeonwuka, C. D., Liyanage, V. R. B., & Rastegar, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090645 · Cited by 118
Sex-dependent association of common variants of microcephaly genes with brain structure
Rimol, L. M., Agartz, I., Djurovic, S., Brown, A. A., Roddey, J. C., Kähler, A. K., Mattingsdal, M., Athanasiu, L., Joyner, A. H., Schork, N. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908454107 · Cited by 112
Treating Rett syndrome: from mouse models to human therapies
Vashi, N., & Justice, M. J. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09793-5 · Cited by 116
Transcriptional regulation by small RNAs at sequences downstream from 3′ gene termini
Yue, X., Schwartz, J. C., Chu, Y., Younger, S. T., Gagnon, K. T., Elbashir, S. M., Janowski, B. A., & Corey, D. R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.400 · Cited by 112
Jentarra, G. M., Olfers, S., Rice, S. G., Srivastava, N., Homanics, G. E., Blue, M. E., Naidu, S., & Narayanan, V. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-19 · Cited by 112
Joyner, A. H., Cooper Roddey, J., Bloss, C. S., Bakken, T. E., Rimol, L. M., Melle, I. S., Agartz, I., Djurovic, S., Topol, E. J., Schork, N. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901866106 · Cited by 114
MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes
Boxer, L. D., Renthal, W. R., Greben, A. W., Whitwam, T., Silberfeld, A., Stroud, H., Li, E., Yang, M. G., Kinde, B., Griffith, E. C., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.10.032 · Cited by 115
Matrisciano, F., Tueting, P., Maccari, S., Nicoletti, F., & Guidotti, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.274 · Cited by 110
The role of methyl-binding proteins in chromatin organization and epigenome maintenance
Fournier, A., Sasai, N., Nakao, M., & Defossez, P. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr040 · Cited by 120
Histone deacetylase 3 associates with MeCP2 to regulate FOXO and social behavior
Nott, A., Cheng, J., Gao, F., Lin, Y.-T., Gjoneska, E., Ko, T., Minhas, P., Zamudio, A. V., Meng, J., Zhang, F., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4347 · Cited by 110
Genomic distribution and possible functions of DNA hydroxymethylation in the brain
Wen, L., & Tang, F. (2014) · Genomics · doi:10.1016/j.ygeno.2014.08.020 · Cited by 115
Paciorkowski, A. R., Traylor, R. N., Rosenfeld, J. A., Hoover, J. M., Harris, C. J., Winter, S., Lacassie, Y., Bialer, M., Lamb, A. N., Schultz, R. A., et al. (2013) · neurogenetics · doi:10.1007/s10048-013-0356-y · Cited by 109
Epigenetic modifications in the nervous system and their impact upon cognitive impairments
Rudenko, A., & Tsai, L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.043 · Cited by 111
ATXN1 Protein Family and CIC Regulate Extracellular Matrix Remodeling and Lung Alveolarization
Lee, Y., Fryer, J. D., Kang, H., Crespo-Barreto, J., Bowman, A. B., Gao, Y., Kahle, J. J., Hong, J. S., Kheradmand, F., Orr, H. T., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.08.017 · Cited by 113
Self-citationGenetic control of postnatal human brain growth
van Dyck, L. I., & Morrow, E. M. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000405 · Cited by 114
Kosillo, P., & Bateup, H. S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.700968 · Cited by 112
Rahn, E. J., Karlsson, M. G., & Sweatt, J. D. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.06.008 · Cited by 113
MeCP2: the long trip from a chromatin protein to neurological disorders
Ausió, J., Paz, A. M. D., & Esteller, M. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.004 · Cited by 108
Lü, H., Ash, R. T., He, L.-J., Kee, S. E., Wang, W., Yu, D., Hao, S., Meng, X., Ure, K., Ito, A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.07.018 · Cited by 108
Self-citationNitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
Tu, S., Akhtar, M. W., Escorihuela, R. M., Amador‐Arjona, A., Swarup, V., Parker, J., Zaremba, J. D., Holland, T., Bansal, N., Holohan, D. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01563-8 · Cited by 104
Sensitive time-windows for susceptibility in neurodevelopmental disorders
Meredith, R. M., Dawitz, J., & Kramvis, I. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.005 · Cited by 108
Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder
Banerjee, A., Miller, M. T., Li, K., Sur, M., & Kaufmann, W. E. (2018) · Brain · doi:10.1093/brain/awy323 · Cited by 115
Epigenetic regulation in neurodevelopment and neurodegenerative diseases
Gapp, K., Woldemichael, B. T., Bohacek, J., & Mansuy, I. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.040 · Cited by 110
Substantial DNA methylation differences between two major neuronal subtypes in human brain
Kozlenkov, A., Wang, M., Roussos, P., Rudchenko, S., Barbu, M., Bibikova, M. V., Klotzle, B., Dwork, A. J., Zhang, B., Hurd, Y. L., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1304 · Cited by 130
Parrish, R. R., Albertson, A. J., Buckingham, S. C., Hablitz, J. J., Mascia, K. L., Haselden, W. D., & Lubin, F. D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.029 · Cited by 107
Calfa, G. D., Hablitz, J. J., & Pozzo‐Miller, L. D. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00800.2010 · Cited by 106
Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin
Hansen, J. C., Ghosh, R. P., & Woodcock, C. L. F. (2010) · IUBMB Life · doi:10.1002/iub.386 · Cited by 114
Transcriptional Silencers: Driving Gene Expression with the Brakes On
Segert, J. A., Gisselbrecht, S. S., & Bulyk, M. L. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.002 · Cited by 116
Genetic Factors Predisposing to Systemic Lupus Erythematosus and Lupus Nephritis
Ramos, P. S., Brown, E. E., Kimberly, R. P., & Langefeld, C. D. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.01.007 · Cited by 104
Chapleau, C. A., Larimore, J. L., Theibert, A. B., & Pozzo‐Miller, L. D. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9027-6 · Cited by 112
Experience-Dependent Retinogeniculate Synapse Remodeling Is Abnormal in MeCP2-Deficient Mice
Noutel, J., Hong, Y. K., Leu, B., Kang, E., & Chen, C. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.001 · Cited by 103
Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesisPreprint
Bogdanović, O., Long, S. W., van Heeringen, S. J., Brinkman, A. B., Skarmeta, J. L. G., Stunnenberg, H. G., Jones, P. L., & Veenstra, G. J. C. (2011) · Genome Research · doi:10.1101/gr.114843.110 · Cited by 105
Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis
Hu, B., Gharaee-Kermani, M., Wu, Z., & Phan, S. H. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.01.002 · Cited by 102
Yasui, D. H., Scoles, H. A., Horike, S., Meguro‐Horike, M., Dunaway, K. W., Schroeder, D. I., & LaSalle, J. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr357 · Cited by 104
Athira, K. V., Bandopadhyay, S., Samudrala, P. K., Naidu, V. G. M., Lahkar, M., & Chakravarty, S. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001142934 · Cited by 110
Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5pPreprint
Han, K., Gennarino, V. A., Lee, Y., Pang, K., Hashimoto‐Torii, K., Choufani, S., Raju, C. S., Oldham, M. C., Weksberg, R., RAKIC, P. T., et al. (2013) · Genes & Development · doi:10.1101/gad.207456.112 · Cited by 107
Self-citationTrujillo, C. A., Adams, J. W., Negraes, P. D., Carromeu, C., Tejwani, L., Acab, A., Tsuda, B., Thomas, C. A., Sodhi, N., Fichter, K. M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012523 · Cited by 101
The genetics of cognitive epigenetics
Kleefstra, T., Schenck, A., Kramer, J. M., & van Bokhoven, H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.025 · Cited by 114
Rett Syndrome and Epilepsy: An Update for Child Neurologists
Dolce, A. M., Ben‐Zeev, B., Naidu, S., & Kossoff, E. H. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.11.001 · Cited by 105
Seo, M. K., Ly, N. N., Lee, C. H., Cho, H. Y., Choi, C. M., Nhu, L. H., Lee, J. G., Lee, B. J., Kim, G.-M., Yoon, B. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.009 · Cited by 108
The role of microglia in brain maintenance: implications for Rett syndrome
Derecki, N. C., Cronk, J. C., & Kipnis, J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.002 · Cited by 106
Early postnatal behavioral changes in the Mecp2‐308 truncation mouse model of Rett syndrome
Filippis, B. D., Ricceri, L., & Laviola, G. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00551.x · Cited by 102
Gibson, J. H., Slobedman, B., Kurup, H. K. N., Williamson, S. L., Minchenko, D. O., El‐Osta, A., Stern, J. L., & Christodoulou, J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-53 · Cited by 103
Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation
Wood, K. H., & Zhou, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00093 · Cited by 104
Emerging Role of Epigenetic Mechanisms in Alcohol Addiction
Berkel, T. D. M., & Pandey, S. C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13338 · Cited by 102
Epilepsy in Rett syndrome—The experience of a National Rett Center
Nissenkorn, A., Gak, E., Vecsler, M., Reznik, H., Menascu, S., & Zeev, B. B. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02597.x · Cited by 101
Sun, L., Zhao, J., Gu, X., Liang, L., Wu, S., Mo, K., Feng, J., Guo, W., Zhang, J., Bekker, A., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000894 · Cited by 100
The Epigenetic Landscape of Alcoholism
Krishnan, H. R., Sakharkar, A. J., Teppen, T. L., Berkel, T. D. M., & Pandey, S. C. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801311-3.00003-2 · Cited by 103
Sui, L., Wang, Y., Ju, L.-H., & Chen, M. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.03.007 · Cited by 109
Bellini, E., Pavesi, G., Barbiero, I., Bergo, A., Chandola, C., Nawaz, M., Rusconi, L., Stefanelli, G., Strollo, M., Valente, M. M., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00236 · Cited by 103
Unfolding the pathogenesis of scleroderma through genomics and epigenomics
Tsou, P., & Sawalha, A. H. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.05.004 · Cited by 103
Epigenetics and the nervous system
Mehler, M. F. (2008) · Annals of Neurology · doi:10.1002/ana.21595 · Cited by 101
Heckman, L. D., Chahrour, M. H., & Zoghbi, H. Y. (2014) · eLife · doi:10.7554/elife.02676 · Cited by 98
Self-citationEvolving Role of MeCP2 in Rett syndrome and Autism
LaSalle, J. M., & Yasui, D. H. (2009) · Epigenomics · doi:10.2217/epi.09.13 · Cited by 98
Metadata
- Authors
- Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Zoghbi, Huda Y.
- Venue
- Science
- Published
- 2008-05-30
- Volume
- 320
- Issue
- 5880
- Pages
- 1224-1229
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2443785
- OpenAlex
- W2039276157
- Cited by
- 1,823
- References
- 22
- Citations by year
- 2026: 53 · 2025: 55 · 2024: 76 · 2023: 67 · 2022: 84 · 2021: 95 · 2020: 96 · 2019: 90 · 2018: 69 · 2017: 131 · 2016: 133 · 2015: 113 · 2014: 131 · 2013: 153 · 2012: 128
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Neurological Disorders and Stroke (NS057819, R01NS057819)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 024064, P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MeCP2, Rett syndrome, transcriptional repression, transcriptional activation, CREB1, promoter binding, hypothalamus, gene expression profiling, neuropsychiatric disorders, neurodevelopmental disorders
- MeSH terms
- Animals, Disease Models, Animal, Gene Expression Regulation, Hypothalamic Diseases, Hypothalamus, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Nervous System Diseases, Protein Binding, Repressor Proteins, Transcription Factors, Rett Syndrome, Transcriptional Activation, Cyclic AMP Response Element-Binding Protein, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
